Electronic Health Record Alerts Fail To Improve Acute Kidney Injury Outcomes: Study
Adding automated alerts to medical records failed to improve outcomes for patients with acute kidney injury, Yale researchers determined.
Tag Archives: Kidney
-
-
Invokana, Similar Diabetes Drugs, Linked to High Acid Levels, FDA Warns
The FDA warns that the use of a class of diabetes drugs that includes Invokana could cause dangerously high levels of acid in the blood.
-
Fresenius Dialysis Lawsuits May Be Delayed as Litigation Mounts
Attorneys in Fresenius dialysis litigation ask for more time to prepare for a bellwether selection process as the number of lawsuits passes 400 claims in federal court.
-
Fresenius Lawsuits Continue to Mount Over Sudden Dialysis Problems
Fresenius litigation continues to grow at a rapid pace as rules are laid down for gathering and protecting discovery documents.
-
Illegal Rapamune Marketing Leads to $491M Whistleblower Settlement
Pfizer pays $491M to settle charges that Wyeth illegally marketed the immunosuppressant Rapamune.
-
Rabies Linked to Eight Organ Donor Transplant Deaths: Study
A new study found a number of rabies deaths linked to organ transplants after the initial infection went undetected.
-
Sugary Drinks Increase Kidney Stone Risk: Study
All sugary drinks, not just soda, may increase a person’s risk of developing kidney stones, according to the findings of a new study.
-
Novartis Faces Myfortic Kickback Charges from Justice Dept.
The federal government has filed a lawsuit against Novartis Pharmaceuticals this week, claiming that the pharmaceutical company engaged in an illegal kickback scheme to sell its kidney transplant drug Myfortic.…
-
FDA Warning Letter Sent to Fresenius Over Dialysis Product Design
Federal regulators have issued a warning letter to Fresenius Medical Care, the nation’s largest provider of dialysis services and products, indicating that it failed to adequately study artificial kidneys used…
-
FDA Halts Pediatric Trials for Sensipar After Teen’s Death
Following the death of a 14-year-old test subject, federal health regulators have forced Amgen to halt pediatric trials of the drug Sensipar (cinacalcet), which is currently only approved for use…
